What top creators are saying about BioCryst Pharmaceuticals, Inc.(BCRX)
Biotechnology company focused on rare diseases
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about BioCryst Pharmaceuticals, Inc..
Top creators covering BioCryst Pharmaceuticals, Inc. (BCRX)
The 1 sources with the most insights about BioCryst Pharmaceuticals, Inc. on Kazuha.
Latest insights about BioCryst Pharmaceuticals, Inc. (BCRX)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Yesterday
Significantly undervalued based on the potential of Orladeyo and phase 3 candidate Avotagabart.
Yesterday
Significantly undervalued based on the potential of Orladeyo and phase 3 candidate Avotagabart.
Discussed alongside BioCryst Pharmaceuticals, Inc. (BCRX)
Other assets that creators frequently mention in the same content as BioCryst Pharmaceuticals, Inc..
Frequently asked
Which podcasters and creators cover BioCryst Pharmaceuticals, Inc. (BCRX) the most?
The most active sources covering BioCryst Pharmaceuticals, Inc. (BCRX) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about BioCryst Pharmaceuticals, Inc. (BCRX) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about BioCryst Pharmaceuticals, Inc. (BCRX) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside BioCryst Pharmaceuticals, Inc. (BCRX)?
Creators covering BioCryst Pharmaceuticals, Inc. (BCRX) most frequently also discuss MU, SPRB, AMAT, STX, NVDA. See the "Discussed alongside" section above for full asset pages.